Major bleeding risk and healthcare economic outcomes of non-valvular atrial fibrillation patients newly-initiated with oral anticoagulant therapy in the real-world setting.

Lin, Jay; Trocio, Jeffrey; Gupta, Kiran A; Mardekian, Jack; Lingohr-Smith, Melissa; Menges, Brandy; You, Min Gun; Nadkarni, Anagha

doi:10.1080/13696998.2017.1341902

Record: found
Abstract: found
Article: not found

Major bleeding risk and healthcare economic outcomes of non-valvular atrial fibrillation patients newly-initiated with oral anticoagulant therapy in the real-world setting.

Author(s): Jay Lin ¹ , Jeffrey Trocio ² , Kiran Gupta ³ , Jack Mardekian ² , Melissa Lingohr-Smith ¹ , Brandy Menges ¹ , Min You ³ , Anagha Nadkarni ³

Publication date (Electronic): Sep 2017

Journal: Journal of medical economics

Publisher: Informa UK Limited

Keywords: Non-valvular atrial fibrillation, healthcare costs, healthcare resource use, major bleeding, oral anticoagulants

Read this article at

ScienceOpenPublisher PubMed

Bookmark

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Abstract

This study compared the risk for major bleeding (MB) and healthcare economic outcomes of patients with non-valvular atrial fibrillation (NVAF) after initiating treatment with apixaban vs rivaroxaban, dabigatran, or warfarin.

Related collections

Author and article information

Journal

Journal ID (iso-abbrev): J Med Econ

Title: Journal of medical economics

Publisher: Informa UK Limited

ISSN (Electronic): 1941-837X

ISSN (Print): 1369-6998

Publication date (Electronic): Sep 2017

Volume: 20

Issue: 9

Affiliations

[1 ] a Novosys Health , Green Brook , NJ , USA.

[2 ] b Pfizer, Inc. , New York , NY , USA.

[3 ] c Bristol-Myers Squibb , Lawrenceville , NJ , USA.

Article

DOI: 10.1080/13696998.2017.1341902

PubMed ID: 28604139

SO-VID: 3215dcb7-6cbd-4c58-89a8-d195e65b0db0

History

Keywords: Non-valvular atrial fibrillation,healthcare costs,healthcare resource use,major bleeding,oral anticoagulants

Data availability:

Keywords: Non-valvular atrial fibrillation, healthcare costs, healthcare resource use, major bleeding, oral anticoagulants

Major bleeding risk and healthcare economic outcomes of non-valvular atrial fibrillation patients newly-initiated with oral anticoagulant therapy in the real-world setting.

Read this article at

Abstract

Related collections

Blockchain in Healthcare Today

Author and article information

Journal

Affiliations

Article

History

Comments

Comment on this article

Cited by 11